News

iQ HealthTech Awarded Bronze EcoVadis Medal for ESG Performance

iQ HealthTech has been awarded a Bronze medal by EcoVadis, placing the company in the top 35% of assessed businesses worldwide. This recognition reflects our commitment to responsible practices across ethics, people, and sustainability, and marks a positive step forward in our ESG journey.

EcoVadis Bronze Medal 2025 – iQ HealthTech ranks in the top 35% of companies worldwide for ESG performance
EcoVadis Bronze Medal 2025 – iQ HealthTech ranks in the top 35% of companies worldwide for ESG performance

We’re pleased to announce that iQ HealthTech has been awarded a Bronze medal in our 2025 EcoVadis sustainability assessment, placing us in the top 35% of companies globally.

EcoVadis is a globally recognised provider of business sustainability ratings, used by over 125,000 companies across 180+ countries to benchmark their environmental, social, and ethical performance.

This result highlights the strength of our governance and ethical practices, as well as the progress we’ve made in formalising our people policies, flexible working culture, and sustainability commitments.

Looking ahead, we’re continuing to strengthen our ESG reporting and training. With our new Learning Management System now in place, we’re building the foundations for improved awareness, documentation, and compliance across the business.

This marks an encouraging milestone as we continue to grow responsibly and raise our standards year on year.

About iQ HealthTech

iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. The company delivers innovative Saas and standalone platforms, including iQemo – the industry-leading, end-to-end chemotherapy prescribing and management platform used by NHS and private hospitals in the UK, and a growing number of hospitals worldwide. Learn more

We’re working on an innovative future for healthcare technology

Sign up to our newsletter and stay updated with industry-leading advice, insight and more…

Thank you! Your submission has been received!
Sorry, something went wrong while submitting the form.

About iQemo

iQemo, from iQHealthTech, provides specialist chemotherapy prescribing. A complete end-to-end solution that includes predefined regimens, prescribing, scheduling and dispensing, through to chemotherapy administration and reporting. iQemo is used in NHS Trusts and private hospitals in the UK, and in a growing number of hospitals worldwide. Learn More

About iQ HealthTech

iQ HealthTech was established in 2011 by a founding-team of software developers and a practicing consultant oncologist. With a team of subject experts working across design, development, implentations and customer success, the company develops people-centric technology with the goal of improving patient outcomes, everywhere. Learn more

Would you like more information about iQemo?

We'd love to discuss how iQemo could support your organisation, people and patients.

Get in touch